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involved patients with complex disease and
other mitigating factors. We therefore con-
tinue not only to use the connector but to
promote its use to our colleagues.
R. L. Quigley, MD, PhD
Division of Cardiothoracic Surgery
Albert Einstein Medical Center
Philadelphia, PA 19141
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Reply to the Editor:
Since submission of our report, we too
have begun to administer clopidogrel rou-
tinely, 75 mg by mouth every morning
starting on the first postoperative morning
and continuing through the second postop-
erative month. We have detected no new
problems.
Baron Hamman, MD
Division of Cardiovascular Surgery
Baylor University Medical Center
Dallas, TX 75246
doi:10.1067/mtc.2003.283
Symmetry aortic connector system
To the Editor:
The article by Donsky and colleagues1 re-
garding thrombotic occlusion of vein grafts
after use of the Symmetry aortic connector
system (St Jude Medical, Inc, St Paul,
Minn) aroused my interest because of my
experience with this device. Similar to the
authors’ experience, I have had occlusion
of the aortic orifice at the connector site
within a few months of surgery in 3 pa-
tients. All patients were obese, diabetic,
and hypertensive, as in the patients refer-
enced in the article. It has been my expe-
rience, however, that these occlusions oc-
cur when a small (gray) connector is used,
but not when a large (blue or purple) con-
nector can be used. The authors do not
mention the size of the connectors used in
their case report. I would like to ask their
opinion regarding my observation.
Terrill E. Theman, MD
701 Ostrum St, Suite 201
Bethlehem, PA 18015
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Reply to the Editor:
Size of the connector was not recorded in
the permanent record.
Baron Hamman, MD
Division of Cardiovascular Surgery
Baylor University Medical Center
Dallas, TX 75246
doi:10.1067/mtc.2003.285
Does normothermic cardiopulmonary
bypass influence clinical outcomes,
cytokine production, and in vitro
platelet function?
To the Editor:
We read with great interest the article by
Gaudino and associates1 in the June 2002
issue of this Journal. They evaluated pro-
spectively the clinical outcomes of pa-
tients and some inflammatory and fi-
brinolytic markers such as C-reactive
protein, interleukin (IL) 6, prothrombin
time, and platelets. They concluded that
normothermic systemic perfusion did not
influence the clinical course or the extent
of inflammatory and hemostatic activa-
tion in patients undergoing primary iso-
lated coronary artery bypass. The mark-
ers were determined before surgical
inetervention; 21, 48, and 72 hours thereaf-
ter; and at hospital discharge.
We2 previously investigated platelet ac-
tivation and aggregation up to 24 hours
after operation by examining the serial
changes of platelet count and small particle
formation in patients undergoing coronary
artery bypass with normothermic cardio-
pulmonary bypass (CPB). Platelet counts
decreased during CPB, and 24 hours after
CPB they had increased to approximately
half the pre-CPB levels. Small particle for-
mation was the main type of platelet aggre-
gation observed before surgery. Medium
particle formation was also recognized, but
no patient had large particle formation. Af-
ter systemic heparinization, small and me-
dium particle formation occurred. One
hour after the initiation of CPB, only small
particles were seen; 2 hours after the end of
CPB, no small particles were observed.
Small particle formation was the main
platelet aggregation type observed 24 hours
after CPB.
We3 also evaluated cytokine production
and levels of thrombomodulin and soluble
endothelium-derived adhesion molecules
in patients undergoing coronary artery by-
pass under normothermic CPB. The study
was scheduled also up to 24 hours after the
operation. IL-6 values were elevated min-
imally after 30 minutes of CPB, and they
showed a surge at the end of CPB or 2
hours after CPB in some patients. Other
patients showed stable levels. The IL-6 val-
ues were reduced after 2 hours, but 24
hours after CPB they were still higher than
the initial levels. There was a huge differ-
ence in IL-6 changes among patients. A
surge of IL-8 occurred 2 hours after CPB,
and the values returned to the initial levels
24 hours after CPB. Thrombomodulin lev-
els were reduced 30 minutes after the ini-
tiation of CPB; however, they began to
recover during CPB. The levels returned to
the initial levels 2 hours after CPB and
exceeded them 24 hours after CPB. Levels
of soluble endothelium-derived adhesion
molecules were reduced after 30 minutes of
CPB; they returned to the initial levels 2
hours after CPB and exceeded them 24
hours after CPB.
Our studies may endorse the conclu-
sions of Gaudino and associates. CPB for
less than 3 hours does not influence clinical
outcomes, and in vitro studies, such as
platelet function and cytokine production,
did not differ under normothermic and
moderate hypothermic conditions.
Yoshio Misawa, MD
Katsuo Fuse, MD
Division of Cardiovascular Surgery
Jichi Medical School
3311-1 Yakushiji, Minami-kawachi
Tochigi, 329-0498, Japan
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